drugset / Trial / NCT00261443

A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania

NCT00261443

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this clinical research study is to learn if outpatients with bipolar mania who are partially nonresponsive to lithium or valproate monotherapy can achieve stable symptoms on a combination treatment of aripiprazole plus lithium or valproate.

Timeline

Start
2005-09
Primary completion
2009-06
Completion
2009-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Aripiprazole Other / unclassified Oral
Background Lithium Unknown Oral
Background Valproate Small molecule Oral

Indications